期刊文献+

黄连的化学成分研究 被引量:13

Chemical Constituents from Coptis chinensis
下载PDF
导出
摘要 目的:研究毛茛科植物黄连Coptis chinensis Franch.的化学成分。方法:利用柱色谱、凝胶柱色谱、高效液相色谱等分离技术对黄连的95%乙醇提取物进行分离,根据其所得化合物的理化性质与UV、IR、MS、NMR等光谱数据鉴定其结构。结果:从黄连的95%乙醇提取物的氯仿萃取部分分离得到7个成分,分别鉴定为甲基小檗碱(1)、8,9-dihydroxy-1,5,6,10b-tetrahydro-2H-pyrrolo[2,1-α]isoquinolin-3-one(2)、(±)5,5'-二甲氧基落叶松脂醇(3)、3,4-二羟基苯乙醇(4)、methyl-5-O-feruloylquinate(5)、ethyl-5-O-feruloylquinate(6)和apocynol(7)。结论:其中化合物3为首次从该属植物中分离得到,化合物5~7为首次从该植物中分离得到。 Objective: To study the chemical constituents of Coptis chinensis. Methods: The compounds were separated and puri- fied by column chromatography and their structures were identified by spectroscopic methods. Results:Seven compounds were isolated from the chloroform extract of Coptis chinensis, whose structures were determined as worenine (1), 8,9-dihydroxy-1,5,6, 10b-tetra- hydro-2 H-pyrrolo [ 2,1 -a ] isoquinoliu-3 -one ( 2 ), ( ± ) -5,5 '-dimethoxy-larieiresinol ( 3 ), 3,4-dihydroxy-phenylethylalcohol ( 4 ), meth- yl-5-O-feruloylquinate ( 5 ), ethyl-5-O- feruloylquinate (6), apocynol ( 7 ). Conclusion : Compounds ( 3 ) is isolated from this genus for the first time, compounds ( 5 ), ( 6 ), ( 7 ) are isolated from this plant for the first time.
出处 《中药材》 CAS CSCD 北大核心 2012年第9期1438-1441,共4页 Journal of Chinese Medicinal Materials
基金 江西省科技支撑计划项目(2012IBBG70019)
关键词 结构鉴定 柱色谱法 黄连 氯仿提取物 Structural identification Column chromatography Coptis chinensis Franch. Chloroform extract
  • 相关文献

参考文献7

  • 1余园媛,王伯初,彭亮,王晶波,曾辰.黄连的药理研究进展[J].重庆大学学报(自然科学版),2006,29(2):107-111. 被引量:200
  • 2Mark Cushman, Frederick W Dekow. Conformations, DNA Binding Parameters, and Antileukemic Activity of Certain Cytotoxic Protoberberine Alkaloids [ J ]. Journal of Medicinal Chemistry, 1979,22(3 ) :331-333.
  • 3Lan Xiang, Dongming Xing, Wei Wang, et al. Alkaloids from Portulaca oleracea L. [ J ]. Phytochemistry, 2005,66 (21) :2595-2601.
  • 4Yoshiteru Ida, Yohko Satoh, Masumi Ohtsuka, et al. Phenolic constituents of Phellodendron amurense bark [ J ]. Phytochemistry, 1994,35 ( 1 ) :209-215.
  • 5薛震,李帅,王素娟,杨永春,贺定祥,冉光伦,孔令忠,石建功.山慈菇Cremastra appendiculata化学成分[J].中国中药杂志,2005,30(7):511-513. 被引量:64
  • 6Gentr E J, Jampani H B, Keshavarz-Shokri A, et al. Antitubercular natural products: berberine from the roots of commercial Hydrastis canadensis powder [ J ]. J Nat Prod, 1998,6(10) :1187-1193.
  • 7Donald R Dimmel, Donaline Shepard. Regioselective Alkylation of Anthrahydroquinone and Anthrone in Water with Quinonemethides and Other Alkylating Agent [ J]. Org Chem, 1982,47 ( 1 ) : 22-29.

二级参考文献39

  • 1王丹丹 刘盛泉 陈英灰 等.紫丁香有效成分的研究.药学学报,1982,17(12):951-4.
  • 2中国中医药管理局 《中华本草》编委会.中华本草[M].上海:上海科学技术出版社,1999.827-830.
  • 3中华人民共和国卫生部药典委员会 275-276.中华人民共和国药典[M].北京:人民卫生出版社,化学工业出版社,1990..
  • 4LEE D U,KANG Y J.Effects of 13-alkyl-substituted Berberine Alkaloids on the Expression of COX-Ⅱ,TNF-α,iNOS and IL-12 Production in LPS-stimulated Macrophages[J].Life Sciences,2003,73(3):1401-1412.
  • 5ZENG X H,ZENG X J.Efficacy and Safety of Berberine for Congestive Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomoyopathy[J].The American Iournal of Cardiology,2003,92(7):173-176.
  • 6KUO C L,CHI C W.The Anti-inflammatory Potential of Berberine in Vitro and in Vivo[J].Cancer Letters,2004,203(9):127-130.
  • 7MITANIN,MURAKAMIK,YAMAURAT.Inhibitory Effect of Berberine on the Mediastinal Lymph Node Metastasis Produced by Orthotopic Implantation of Lewis Lung Carcinoma[J].Cancer Letters,2001,165(11):359 -427.
  • 8MANRINOVA E K,NIKOLOVA D B,POPOVA D N,et al.Suppression of Experimental Antoimmune Tubulointerstitial Nephritis in BALB/Cmice by Berberine[J].Immunopharmacology,2000,48 (12):9-16.
  • 9.中国药典一部[M].,2000.27.
  • 10Y W Leong,C C Kang,L J Harrison,et al.Phenanthrenes,dihydrophenanthrenes and bibenzyls from the orchid Bulbophyllum vaginatum.Phytochemistry,1997,44(1):157.

共引文献262

同被引文献251

引证文献13

二级引证文献416

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部